Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 256315Generated: October 26, 2026

Ciprofloxacin → 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acid

https://huagongshe.com/reaction/256315

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCiprofloxacinHCID 2764—
ReactantPotassium BicarbonateHCID 516893—
Reactant4-(Bromomethyl)-5-methyl-1,3-dioxol-2-oneHCID 10774141—
SolventDimethylformamideHCID 6228—
Product1-Cyclopropyl-6-fluoro-1,4-dihydro-7-[4-(5-methyl-2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-4-oxo-3-quinolinecarboxylic acidHCID 13673272—

Reaction Steps

1.15 g (3.5 mmoles) of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid are stirred in 20 ml of dimethylformamide with 0.85 g (4.4 mmoles) of 4-bromomethyl-5-methyl-1,3-dioxol-2-one and 0.42 g (4.2 mmoles) of powdered potassium bicarbonate for 3 days, while cooling with ice. The mixture is concentrated in vacuo, the residue is stirred with 20 ml of water, the resulting greasy product is dissolved in methanol and the solution is filtered. The filtrate is left to stand at room temperature for 2 days and the colorless crystals which have precipitated are isolated.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04703047
Source datasetuspto-grants-1987_10
ORD IDord-a73071cede0544c8b4b53d87ab259d7d
Source noteuspto-grants-1987_10